|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLE |
Correspondence to Stéphane Sebille: stephane.sebille{at}univ-poitiers.fr
We present here evidence for the enhancement of an inositol 1,4,5-trisphosphate (IP3) mediated calcium signaling pathway in myotubes from dystrophin-deficient cell lines (SolC1(–)) as compared to a cell line from the same origin but transfected with mini-dystrophin (SolD(+)). With confocal microscopy, we demonstrated that calcium rise, induced by the perifusion of a solution containing a high potassium concentration, was higher in SolC1(–) than in SolD(+) myotubes. The analysis of amplitude and kinetics of the calcium increase in SolC1(–) and in SolD(+) myotubes during the exposure with SR Ca2+ channel inhibitors (ryanodine and 2-APB) suggested the presence of two mechanisms of SR calcium release: (1) a fast SR calcium release that depended on ryanodine receptors and (2) a slow SR calcium release mediated by IP3 receptors. Detection analyses of mRNAs (reverse transcriptase [RT]-PCR) and proteins (Western blot and immunolocalization) demonstrated the presence of the three known isoforms of IP3 receptors in both SolC1(–) and SolD(+) myotubes. Furthermore, analysis of the kinetics of the rise in calcium revealed that the slow IP3-dependent release may be increased in the SolC1(–) as compared to the SolD(+), suggesting an inhibitory effect of mini-dystrophin in this signaling pathway. Upon incubation with pertussis toxin (PTX), an inhibitory effect similar to that of the IP3R inhibitor (2-APB) was observed on K+-evoked calcium release. This result suggests the involvement of a Gi protein upstream of the IP3 pathway in these stimulation conditions. A hypothetical model is depicted in which both Gi protein and IP3 production could be involved in K+-evoked calcium release as well as a possible interaction with mini-dystrophin. Our findings demonstrate the existence of a potential relationship between mini-dystrophin and SR calcium release as well as a regulatory role of mini-dystrophin on intracellular signaling.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Labarque, K. Freson, C. Thys, C. Wittevrongel, M. F. Hoylaerts, R. De Vos, N. Goemans, and C. Van Geet Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery Hum. Mol. Genet., February 1, 2008; 17(3): 357 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vandebrouck, J. Sabourin, J. Rivet, H. Balghi, S. Sebille, A. Kitzis, G. Raymond, C. Cognard, N. Bourmeyster, and B. Constantin Regulation of capacitative calcium entries by {alpha}1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of {alpha}1-syntrophin FASEB J, February 1, 2007; 21(2): 608 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Balghi, S. Sebille, L. Mondin, A. Cantereau, B. Constantin, G. Raymond, and C. Cognard Mini-dystrophin Expression Down-regulates IP3-mediated Calcium Release Events in Resting Dystrophin-deficient Muscle Cells J. Gen. Physiol., July 31, 2006; 128(2): 219 - 230. [Abstract] [Full Text] [PDF]
|
|
|
|
